Goldman Sachs·2026-09-18StrategyJAPAN WEEKLY KICKSTART: Has it been better to travel or to arrive with the BOJ?TOPIX: GS 12-month target12m
Goldman Sachs·2026-09-18SectorCHINA PROPERTY: Expert call: medium-term supply gap, local execution in line, long-term outlook & property tax1109.HK001979.SZ0817.HK0960.HK2202.HK3900.HK600048.SH
Goldman Sachs·2026-09-18SectorEuropean Metals and Mining: Coverage summary, forecasts and spot pricing scenariosGLEN.LNHY.OLRIO.LANTO.LBHP.LLUN.TOMT.AS
Goldman Sachs·2026-09-18StrategyForeign selling in Korea continues this week; Hedge funds remain net sellers in EM Asia in September MTD, while China exposure sees a recovery
Goldman Sachs·2026-09-18StrategyPRECIOUS ANALYST: Fed Hikes to Slow, Rather than Derail, the Gold RallyGold price: GS forecastend-2027Gold price: GS fair valueend-2026
Goldman Sachs·2026-09-18SectorGlobal Healthcare: Pharmaceuticals: China Biopharma: Continued momentum amidst emerging policy dynamics1801.HKREGNSNY.US
Goldman Sachs·2026-09-17StrategyUS EQUITY VIEWS: Over-earning, but not an earnings bubbleS&P 500: GS 12-month target12m
Goldman Sachs·2026-09-17SectorJAPAN TELECOM SERVICES: Sector investment strategy: Signs of easing in mobile competition, shifting to growth phase on higher ARPU; Buy on NTT Softbank9432.T9434.T4755.T9433.T
Goldman Sachs·2026-09-17SectorGLOBAL HEALTHCARE: PHARMACEUTICALS: Assessing Oral SERDs for Adjuvant Breast Cancer: An Emerging Blockbuster Class; LLY’s Imlunestrant an Underappreciated AssetLLYAZN.LROG.SW
Goldman Sachs·2026-09-17MacroHong Kong: Hong Kong’s First Five Year Plan: Identifying Sources of Structural Growth
Goldman Sachs·2026-09-17CreditGLOBAL CREDIT TRADER: An Update on AI-Related Debt IssuanceHyperscaler gross debt issuance: GS forecast2027
Goldman Sachs·2026-09-17StrategyGOAL POST: The name is bond — rethinking duration in balanced portfolios